2009 | OriginalPaper | Hoofdstuk
Tip
Swipe om te navigeren naar een ander hoofdstuk
Gepubliceerd in:
Meest gestelde vragen over hypertensie
De laatste jaren zijn resultaten van vele hypertensie trials, gepubliceerd. Een deel daarvan richtte zich speciaal op diabetespatiënten (meestal type 2) of hadden een subgroep van diabeten. Regelmatig worden er nieuwe Europeserichtlijnen voor de diagnostiek en behandeling van hypertensie bekend gemaakt, de meest recente in 2007 (1).
Log in om toegang te krijgen
1.
go back to reference Mancia G, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28:1462–536. PubMed Mancia G, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007; 28:1462–536.
PubMed
2.
go back to reference Hanson L, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with Hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–62. CrossRef Hanson L, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with Hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–62.
CrossRef
3.
go back to reference Tuomilehto J, et al. Effects of Calcium-Channel Blockade in Older patients with Diabetes and Systolic Hypertension. N Engl J Med 1999; 340: 677–84. PubMedCrossRef Tuomilehto J, et al. Effects of Calcium-Channel Blockade in Older patients with Diabetes and Systolic Hypertension. N Engl J Med 1999; 340: 677–84.
PubMedCrossRef
4.
go back to reference UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 17: 703–13. CrossRef UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 17: 703–13.
CrossRef
5.
go back to reference UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998; 317: 713–20. CrossRef UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998; 317: 713–20.
CrossRef
6.
go back to reference Holman RR, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359:1565–76. PubMedCrossRef Holman RR, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359:1565–76.
PubMedCrossRef
7.
go back to reference The ALLHAT Officers and Coordinators for the ALLHAT Collaborate Research. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The anthypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288: 2982–97. The ALLHAT Officers and Coordinators for the ALLHAT Collaborate Research. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The anthypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288: 2982–97.
8.
go back to reference Östergren J, Poulter NR, Sever PS, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. J Hypertens 2008; 26: 2103–11. PubMedCrossRef Östergren J, Poulter NR, Sever PS, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. J Hypertens 2008; 26: 2103–11.
PubMedCrossRef
9.
go back to reference Gaede P, Vedel P, Parring HH, Peterson O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and micro-albuminuria: The Steno type 2 randomised study. Lancet 1999; 353: 617–22. PubMedCrossRef Gaede P, Vedel P, Parring HH, Peterson O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and micro-albuminuria: The Steno type 2 randomised study. Lancet 1999; 353: 617–22.
PubMedCrossRef
- Titel
- Wat is de eerste keus bij behandeling van hypertensie bij type 2 diabetes?
- DOI
- https://doi.org/10.1007/978-90-313-7340-6_10
- Auteur:
-
Dr. J. W. F. Elte
- Uitgeverij
- Bohn Stafleu van Loghum
- Volgnummer
- 10